The potential of annexin-labelling for the diagnosis and follow-up of glaucoma

@article{Normando2013ThePO,
  title={The potential of annexin-labelling for the diagnosis and follow-up of glaucoma},
  author={Eduardo Normando and Lisa A. Turner and Maria Francesca Cordeiro},
  journal={Cell and Tissue Research},
  year={2013},
  volume={353},
  pages={279-285}
}
Glaucoma is one of the leading causes of blindness in developed countries and is mainly attributable to the apoptosis of retinal ganglion cells (RGCs). Although several diagnostic tools have been developed to detect and monitor this disease, none has the requisite sensitivity to identify it at a preclinical stage or to perceive small changes in retinal health over short periods. Specifically, irreversible visual changes occur before neuronal damage is discovered. The most widely accepted in… CONTINUE READING
1
Twitter Mention

Citations

Publications citing this paper.

References

Publications referenced by this paper.
SHOWING 1-10 OF 78 REFERENCES

Target pressures in glaucoma.

VIEW 4 EXCERPTS
HIGHLY INFLUENTIAL

Age-related losses of retinal ganglion cells and axons.

VIEW 2 EXCERPTS
HIGHLY INFLUENTIAL

Imaging and dosimetry of 99mTc EC annexin V: preliminary clinical study targeting apoptosis in breast tumors.

VIEW 4 EXCERPTS
HIGHLY INFLUENTIAL

Number of people with glaucoma worldwide.

VIEW 2 EXCERPTS
HIGHLY INFLUENTIAL

AIDS as immune system activation. Key questions that remain.

VIEW 3 EXCERPTS
HIGHLY INFLUENTIAL

[Apoptosis in the pathogenesis and treatment of disease].

VIEW 3 EXCERPTS
HIGHLY INFLUENTIAL